These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23971197)

  • 1. Imidazole-induced contractility of vascular smooth muscle cells in the presence of U-73122, ODQ, indomethacin and 7-nitroindazole.
    Wiciński M; Grześk G; Malinowski B; Grześk E; Sinjab AT; Krzyzanowski M; Michalska A; Bylina D; Dziecioł J; Szadujkis-Szadurska K; Czeczuk A
    Pol J Vet Sci; 2013; 16(2):293-7. PubMed ID: 23971197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
    Zingarelli B; Haskó G; Salzman AL; Szabó C
    Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
    Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
    Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective inhibition of soluble guanylyl cyclase on the K(Ca) channel activity in coronary artery smooth muscle.
    Li PL; Jin MW; Campbell WB
    Hypertension; 1998 Jan; 31(1 Pt 2):303-8. PubMed ID: 9453320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of guanylyl cyclase activators on the reaction of tracheal smooth muscle contraction.
    Glaza I; Szadujkis-Szadurski L; Szadujkis-Szadurski R; Gajdus M; Rzepka A; Gurtowska N
    Postepy Hig Med Dosw (Online); 2011 Aug; 65():496-500. PubMed ID: 21918251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one inhibits neurite outgrowth and causes neurite retraction in PC12 cells independently of soluble guanylyl cyclase.
    Lee HG; Kim SY; Kim du S; Seo SR; Lee SI; Shin DM; De Smet P; Seo JT
    J Neurosci Res; 2009 Jan; 87(1):269-77. PubMed ID: 18711750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
    Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
    Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
    Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
    Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum.
    Filippi S; Crescioli C; Vannelli GB; Fazzini A; Natali A; Riffaud JP; Maggi M; Ledda F
    Int J Androl; 2003 Apr; 26(2):101-8. PubMed ID: 12641828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased aortic smooth muscle contraction in a rat model of multibacterial sepsis.
    Wang C; Mansard A; Giummelly P; Atkinson J
    Fundam Clin Pharmacol; 2004 Dec; 18(6):679-83. PubMed ID: 15548239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW; Gath I; Förstermann U; Nawrath H
    Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of nitric oxide-soluble guanylyl cyclase pathway in the control of maximal dentate gyrus activation in the rat.
    Sardo P; Carletti F; D'Agostino S; Rizzo V; Ferraro G
    J Neural Transm (Vienna); 2006 Dec; 113(12):1855-61. PubMed ID: 16736237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.
    Spolidório PC; Echeverry MB; Iyomasa M; Guimarães FS; Del Bel EA
    Psychopharmacology (Berl); 2007 Dec; 195(2):183-92. PubMed ID: 17661019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles.
    McGuire JJ; Hollenberg MD; Andrade-Gordon P; Triggle CR
    Br J Pharmacol; 2002 Jan; 135(1):155-69. PubMed ID: 11786491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neuronal nitric oxide synthase and soluble guanylate cyclase prevents depression-like behaviour in rats exposed to chronic unpredictable mild stress.
    Yazir Y; Utkan T; Aricioglu F
    Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):154-60. PubMed ID: 22385503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
    Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
    Hussain AS; Marks GS; Brien JF; Nakatsu K
    Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2-nitrate-1,3-dibuthoxypropan, a new nitric oxide donor, induces vasorelaxation in mesenteric arteries of the rat.
    França-Silva MS; Luciano MN; Ribeiro TP; Silva JS; Santos AF; França KC; Nakao LS; Athayde-Filho PF; Braga VA; Medeiros IA
    Eur J Pharmacol; 2012 Sep; 690(1-3):170-5. PubMed ID: 22796675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
    Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.